Cargando…
Cell wall skeleton of Mycobacterium bovis BCG enhances the vaccine potential of antigen 85B against tuberculosis by inducing Th1 and Th17 responses
A safe and effective adjuvant is necessary to induce reliable protective efficacy of the protein-based vaccines against tuberculosis (TB). Mycobacterial components, such as synthetic cord factor and arabinogalactan, have been used as one of the adjuvant components. Mycobacterium bovis bacillus Calme...
Autores principales: | Back, Yong Woo, Choi, Seunga, Choi, Han-Gyu, Shin, Ki-Won, Son, Yeo-Jin, Paik, Tae-Hyun, Kim, Hwa-Jung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407753/ https://www.ncbi.nlm.nih.gov/pubmed/30849108 http://dx.doi.org/10.1371/journal.pone.0213536 |
Ejemplares similares
-
A Dendritic Cell-Activating Rv1876 Protein Elicits Mycobacterium Bovis BCG-Prime Effect via Th1-Immune Response
por: Choi, Seunga, et al.
Publicado: (2021) -
Mycobacterium tuberculosis RpfE-Induced Prostaglandin E2 in Dendritic Cells Induces Th1/Th17 Cell Differentiation
por: Park, Hye-Soo, et al.
Publicado: (2021) -
A retrospective study of immunotherapy using the cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin (BCG-CWS) for cervical cancer
por: Shibata, Takeo, et al.
Publicado: (2022) -
Protection Induced by Simultaneous Subcutaneous and Endobronchial Vaccination with BCG/BCG and BCG/Adenovirus Expressing Antigen 85A against Mycobacterium bovis in Cattle
por: Dean, Gillian S., et al.
Publicado: (2015) -
Mycobacterium tuberculosis Rv2005c Induces Dendritic Cell Maturation and Th1 Responses and Exhibits Immunotherapeutic Activity by Fusion with the Rv2882c Protein
por: Back, Yong Woo, et al.
Publicado: (2020)